Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomet Planning Two Product Introductions, One Submission In October

This article was originally published in The Gray Sheet

Executive Summary

Biomet expects to make further inroads into the spinal fixation market with the introduction of the Omega 21 rod and screw spinal fixation system in the U.S. this month, President and CEO Dane Miller, PhD, told investors at the Warburg Dillon Read Global Life Sciences Conference Sept. 29 in New York City.

You may also be interested in...



Sulzer Medica Debuts Metasul Metal-On-Metal Wear-Resistant Hip Joint

Roll-out of Sulzer Medica's Metasul metal-on-metal hip joint replacement technology Aug. 10 following recent FDA market clearance makes it "the first medical device company to launch the metal-on-metal technology for use in hip joint replacement surgery in the U.S.," Sulzer claims.

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
UsernamePublicRestriction

Register

MT012379

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel